4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002618
President sold 30,000 shares at an average $56.58 ($1,697,386)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-04 | Sale : show line 2 in the form | −6,371 | $56.05 | $357,095 | 8,629 | D |
| 2021-01-04 | Sale : show line 3 in the form | −3,169 | $57.52 | $182,281 | 5,460 | D |
| 2021-01-04 | Sale : show line 4 in the form | −4,751 | $58.09 | $275,986 | 709 | D |
| 2021-01-04 | Sale : show line 5 in the form | −709 | $59.40 | $42,115 | 0 | D |
| 2021-01-05 | Exercise or conversion : show line 6 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-05 | Sale : show line 7 in the form | −14,637 | $55.98 | $819,379 | 363 | D |
| 2021-01-05 | Sale : show line 8 in the form | −363 | $56.56 | $20,531 | 0 | D |
| Open-market sales · 30,000 sh · avg $56.58 · $1,697,386 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −15,000 | 365,000 | D |
| 2021-01-05 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −15,000 | 350,000 | D |
Loading xslF345X03/doc4.xml…